TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmarelations AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
320,611
|
330,711
|
299,941 |
| Financial expenses |
417
|
431
|
345 |
| Earnings before taxes |
12,877
|
21,716
|
23,132 |
| EBITDA |
12,018
|
21,284
|
23,345 |
| Total assets |
122,814
|
120,405
|
98,208 |
| Current assets |
122,235
|
119,827
|
97,550 |
| Current liabilities |
38,146
|
46,425
|
36,825 |
| Equity capital |
79,387
|
69,141
|
52,566 |
| - share capital |
106
|
106
|
100 |
| Employees (average) |
204
|
227
|
197 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
64.6%
|
57.4%
|
53.5% |
| Turnover per employee |
1,572
|
1,457
|
1,523 |
| Profit as a percentage of turnover |
4.0%
|
6.6%
|
7.7% |
| Return on assets (ROA) |
10.8%
|
18.4%
|
23.9% |
| Current ratio |
320.4%
|
258.1%
|
264.9% |
| Return on equity (ROE) |
16.2%
|
31.4%
|
44.0% |
| Change turnover |
-10,100
|
30,770
|
93,292 |
| Change turnover % |
-3%
|
10%
|
45% |
| Chg. No. of employees |
-23
|
30
|
51 |
| Chg. No. of employees % |
-10%
|
15%
|
35% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.